GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Cyclically Adjusted FCF per Share

BIO.B (Bio-Rad Laboratories) Cyclically Adjusted FCF per Share : $9.08 (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bio-Rad Laboratories's adjusted free cash flow per share for the three months ended in Mar. 2025 was $3.416. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $9.08 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Bio-Rad Laboratories's average Cyclically Adjusted FCF Growth Rate was 10.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.90% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Bio-Rad Laboratories was 93.80% per year. The lowest was -22.40% per year. And the median was 10.50% per year.

As of today (2025-05-16), Bio-Rad Laboratories's current stock price is $234.41. Bio-Rad Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $9.08. Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF of today is 25.82.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bio-Rad Laboratories was 129.56. The lowest was 24.68. And the median was 56.50.


Bio-Rad Laboratories Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Bio-Rad Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Cyclically Adjusted FCF per Share Chart

Bio-Rad Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.61 6.92 7.13 8.07 8.61

Bio-Rad Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.91 8.60 8.19 8.61 9.08

Competitive Comparison of Bio-Rad Laboratories's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF falls into.


;
;

Bio-Rad Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Rad Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.416/134.9266*134.9266
=3.416

Current CPI (Mar. 2025) = 134.9266.

Bio-Rad Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.215 100.684 0.288
201509 1.953 100.392 2.625
201512 0.270 99.792 0.365
201603 -1.110 100.470 -1.491
201606 1.540 101.688 2.043
201609 0.409 101.861 0.542
201612 1.661 101.863 2.200
201703 -3.194 102.862 -4.190
201706 1.098 103.349 1.433
201709 0.276 104.136 0.358
201712 1.436 104.011 1.863
201803 0.436 105.290 0.559
201806 1.693 106.317 2.149
201809 1.328 106.507 1.682
201812 1.693 105.998 2.155
201903 0.642 107.251 0.808
201906 4.417 108.070 5.515
201909 2.302 108.329 2.867
201912 4.563 108.420 5.679
202003 1.362 108.902 1.687
202006 2.462 108.767 3.054
202009 3.840 109.815 4.718
202012 8.125 109.897 9.976
202103 3.116 111.754 3.762
202106 4.353 114.631 5.124
202109 6.476 115.734 7.550
202112 3.790 117.630 4.347
202203 0.582 121.301 0.647
202206 1.206 125.017 1.302
202209 -0.557 125.227 -0.600
202212 1.459 125.222 1.572
202303 2.097 127.348 2.222
202306 2.161 128.729 2.265
202309 1.836 129.860 1.908
202312 1.346 129.419 1.403
202403 1.037 131.776 1.062
202406 1.950 132.554 1.985
202409 3.572 133.029 3.623
202412 2.902 133.157 2.941
202503 3.416 134.927 3.416

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Bio-Rad Laboratories  (NYSE:BIO.B) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bio-Rad Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=234.41/9.08
=25.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Bio-Rad Laboratories was 129.56. The lowest was 24.68. And the median was 56.50.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bio-Rad Laboratories Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Rad Laboratories Business Description

Traded in Other Exchanges
Address
1000 Alfred Nobel Drive, Hercules, CA, USA, 94547
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.